Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$1.78 - $3.41 $3.56 Million - $6.82 Million
-2,000,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$2.5 - $3.72 $750,000 - $1.12 Million
-300,000 Reduced 13.04%
2,000,000 $6.6 Million
Q1 2021

May 17, 2021

BUY
$1.86 - $5.25 $4.28 Million - $12.1 Million
2,300,000 New
2,300,000 $7.71 Million

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ASLAN Pharmaceuticals Ltd


  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.